Australia: The agony of anticipation: When will a prior disclosure mean a patent is invalid?

Clayton Utz Insights

Key Points:

The Full Federal Court has clarified when a disclosure in a prior document will make a subsequent patent invalid, and when a licensee will be considered an "exclusive licensee" with standing to sue.

Inevitability is often associated with death and taxes. Something is "inevitable" only when there can be no other outcome. In a recent decision, the Full Federal Court reiterated that it is this restrictive test that must be applied when determining whether a prior published document "anticipates" a patented invention (Bristol-Myers Squibb Company v Apotex Pty Ltd [2015] FCAFC 2).

A patent will be invalidated for lack of novelty based on a disclosure in a previously published document only if the prior document contains directions which, if followed, "inevitably" result in the patented invention. But if more than one outcome is possible from the directions in the prior document, the subsequent patent is not invalid based on lack of novelty.

Novelty, anticipation and "inevitable result"

In order to qualify for patent protection, an invention must be "novel" (Patents Act 1990, section 18(1)(a)). That is, the invention, as claimed in the patent, must not previously have been performed or disclosed in a prior document. Lack of novelty is therefore a ground to challenge the validity, and seek revocation, of a patent.

Commonly, a prior disclosure relied on to challenge the novelty of a patented invention contains direct statements or illustrations which are alleged to correspond to the elements in the claims of the invention. The question of "inevitable result" arises where the prior document does not contain a comprehensive disclosure of the claimed invention. In such a case, the party seeking revocation must argue that the prior document contains clear and unmistakeable directions which, if followed, would result in the claimed invention. This is also referred to as the "reverse infringement" test: would the directions in the prior document result in something that would be an infringement of the patent? If so, the claimed invention lacks novelty, because a prior publication anticipated the invention, even if a skilled person at the time of the earlier disclosure may not have understood all of the implications.

Were Aripiprazole Crystals B inevitable?

The Full Court decision in BMS v Apotex is part of a long-running dispute relating to the anti-psychotic drug Aripiprazole. The subject of the novelty dispute in the appeal was a form of the drug described in BMS's patent as "crystals B" which were described in the patent as having specified chemical properties. Among other points of appeal, Apotex appealed to the Full Court from the primary judge's decision that a prior document relied on by Apotex did not contain a disclosure sufficient to invalidate claim 12 of BMS's patent based on novelty. The prior document, an earlier patent application, contained instructions that resulted in the creation of Aripiprazole crystals. However, there was conflicting expert evidence as to whether following the instructions in the prior document led as a matter of course to crystals B as characterised in the patent.

Both parties commissioned independent experts to create protocols in accordance with the instructions in the prior document. Apotex's experimental evidence was accepted by the trial judge and showed that following the instructions in the prior patent could lead to the creation of crystals B. However, the prior disclosure was "indifferent" about the exact method to use conducting a final step in the process (a drying step to obtain Aripiprazole in its free base form). The evidence showed that a skilled person following the instructions in the prior disclosure would have had a range of options for this step.

While the method used by Apotex's expert resulted in crystals B, the Full Court agreed with the trial judge that it would have been open to a skilled person following the instructions in the prior disclosure to choose a different method, in which case the resulting crystals would not have had all of the attributes of crystals B. Thus, the result was not "inevitable" and the prior disclosure did not make the patent invalid. The Full Court noted that the onus was on Apotex to establish that the claimed invention would be an inevitable result of following the instruction in the prior disclosure, and that in circumstances where its own evidence recognised a number of possible drying options, Apotex had not achieved this.

The decision confirms that the scope for invalidating an Australian patent based on lack of novelty remains narrow where the prior publication relied upon does not contain a complete disclosure of the claimed invention.

Exclusive patent licences

There was also another interesting aspect to the decision in BMS v Apotex. Under the Act, an exclusive licensee is given the right to commence infringement proceedings. But exactly what is meant by the phrase "exclusive licensee" in this context? Does the licence need to be exclusive for all purposes, or is it sufficient that it is exclusive for one product, or one field of use, or one kind of exploitation?

At the time BMS commenced proceedings against Apotex, BMS had an exclusive licence to advertise, promote, market, distribute and sell Aripiprazole in Australia, but the patentee, Otsuka, retained the exclusive right to manufacture Aripiprazole.

"Exclusive licensee" is defined in the Act as a licence "conferring on the licensee, or on the licensee and persons authorised by the licensee, the right to exploit the patented invention throughout the patent area to the exclusion of the patentee and all other persons". The definition of "exploit" includes "where the invention is a product, make, hire, sell or otherwise dispose of the product, offer to make, hire, sell or otherwise dispose of it, use or import it, or keep it for the purpose of doing any of those things" [emphases added] (Patents Act 1990, Schedule 1).

Relying on the word "or" in the definition of "exploit", BMS argued that a licence to do any of the acts encompassed in the definition of "exploit" to the exclusion of all others should be considered an "exclusive licence". BMS argued that it was not necessary for the licence to encompass all of the acts within the definition of exploit in order to be an exclusive licence.

Rejecting BMS' arguments, the Full Court agreed with the trial judge that "an exclusive licence cannot be one that reserves to the patentee, or any other person, any residual right with respect to the exploitation of the invention, and it followed that there could be only one exclusive licensee". Applying a High Court decision on the definition of "exclusive licence" under the earlier 1952 Act (which refers to a patentee having the right to "make, use exercise and vend" instead of "exploit"), the Full Court held that this difference in wording, and the inclusive wording in the definition of "exploit", should not be regarded as determinative of the meaning of the term "exclusive licensee".

This decision is a salutatory reminder to parties to patent licences to ensure that the prospect of future infringement proceedings is properly considered, and that the licensee is granted all the necessary rights to ensure it has standing to commence proceedings, if appropriate.

Clayton Utz communications are intended to provide commentary and general information. They should not be relied upon as legal advice. Formal legal advice should be sought in particular transactions or on matters of interest arising from this bulletin. Persons listed may not be admitted in all states and territories.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

Some comments from our readers…
“The articles are extremely timely and highly applicable”
“I often find critical information not available elsewhere”
“As in-house counsel, Mondaq’s service is of great value”

Mondaq Advice Centre (MACs)
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at and we will use commercially reasonable efforts to determine and correct the problem promptly.